Navigation Links
Up for Debate This Week: National Service, Mental Health Coverage, and Consumer Product Safety
Date:3/3/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...t. 5 /PRNewswire/ -- EthicAd, a nonprofit organiza...nsumer education, announces,the launch of a new FD...er,understand direct-to-consumer (DTC) advertising...About Prescription Drug Advertising," is,hosted by... and was,developed by the FDA in partnership with ...
(Date:9/5/2008)...Women with hormone-receptor positive, metastatic b...p keep their cancer at bay, but when the tumor bec...ith chemotherapy becomes the only option. But a st... Symposiummay change this approach. Early data su... the tumor, allowing anti-hormonal drugs to do the...
(Date:9/4/2008)..., September 5, 2008Private Medicare Advantage (MA)...er enrollee in 2008 compared to what the same enro...ee-for-service program, according to a new report ...eductions to MA plans mandated by the Medicare Imp...MIPPA) scheduled to take effect beginning in 2010...
(Date:9/4/2008)...tronger labeling about fungal infection risk , ...deral health authorities have asked the manufactur... bolster safety warnings on the risk of developing...Humira, Cimzia, Enbrel and Remicade, belong to a c... alpha blockers (TNF-alpha blockers), which suppre...
Breaking Medicine News(10 mins):Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2Health News:1 step back ... 2 steps forward 2Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3
...from Norwegian Radium Hospital and National Hospit... many cancer Institutes has presented their study ...nd that // long use of Non-steroidal Anti-inflamma...cer in smoking individuals by at least 50%. But th...
...lion people worldwide are estimated to suffer from...se of neurological disability in young adults, and...f life. // Currently marketed therapies afford an ...30% in two-year studies and require frequent injec...
...loning has been a dream come true for the scientis...od and Drug Administration is expected to take an ...that milk // from cloned animals, as well as their...olds the credit when it comes to cloning technique...
...ery could finally prove to be an answer for the pr...e. Surgical treatment of prostate cancer with robo...ring and a // reduction in the post-operative comp...nd leading cause of death among American men. The ...
Other Medicine News:Health News:NSAIDS, Reduces The Risk Of Oral Cancer But Causes Heart Attacks 2Health News:New Hope For Patients With Relapsing Multiple Sclerosis 2Health News:Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer 2
(Date:9/3/2008)...cuss Phase 3 Plans with FDA, PRINCETON, N.J., Sep...ounced today that it successfully completed two ke...y,s new, innovative low-dose, once-weekly,contrac...nternal product,code AG-200-15. The Phase 2b safet...endpoint of ovulation suppression, cycle control a...
(Date:9/3/2008)...s Strong Evidence Pycnogenol(R) Lowers Joint, Pain...Following Cessation of... -- According to the Center for,Disease Control (C...itis,is on the rise. A new study published in the...Pycnogenol(R), bark extract from the French mariti...
(Date:9/3/2008)...RNewswire-FirstCall/ -- A sub-analysis of,the TRIT...th prasugrel,compared with clopidogrel significant...cks (7.4 percent vs. 9.7 percent, p<0.0001), regar...me of an artery-opening,procedure known as percuta...rred spontaneously during the longer-term maintena...
(Date:9/2/2008)...ire-FirstCall/ --, - This Analysis Showed That Mu... by 34% in Patients With Atrial Fibrillation or At...ombotic Therapy, The results of a post-hoc analys...d today at the clinical trial update session of th... Munich, Germany. Previous results,from the landma...
Breaking Medicine Technology:Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers 24898 1LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers 24898 2LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers 24898 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008 2009 Season in the US 2766 1Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008 2009 Season in the US 2766 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008 2009 Season in the US 2766 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008 2009 Season in the US 2766 4Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008 2009 Season in the US 2766 5New HIV Infection Figures from CDC to be Announced on Aug 3 Underscore Need for National AIDS Strategy for the U S 24895 1New HIV Infection Figures from CDC to be Announced on Aug 3 Underscore Need for National AIDS Strategy for the U S 24895 2Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference 6896 1Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference 6896 2
...tations at American Association for Cancer Researc...7 /PRNewswire-FirstCall/ --,Medarex, Inc. today pr...- tumor activity from two separate studies explori...i-CD19 and anti-CD70,antibody-drug conjugates. CD1...body-drug conjugate approach to cancer therapy. Th...
... April 17, 2007 /PRNewswire/ -- Researchers from t...t, MI presented,strong evidence today that an anti...ts could be effective in eventually treating,certa... Prevention Program at Karmanos, and,members of hi...g,that the drug Clioquinol (CQ) appears to have an...
Other Medicine Technology:Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 2Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 3Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 4Alzheimer's Drug Shows Promise in Fighting Cancer 2
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: